Azenta Life Sciences
Mr. Casal has been a director since November 2021. He most recently served as Vice Chair, Audit for KPMG, LLP, the U.S. member firm of KPMG International (KPMGI). Mr. Casal spent over 40 years at KPMG in various roles where he was responsible for creating and executing the strategic vision for the U.S. audit practice before retiring June 30, 2021.
Mr. Casal earned his B.S. in Business Administration from Boston University and is a licensed CPA in Massachusetts and New York.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Azenta Life Sciences
3 followers
Azenta (Nasdaq: AZTA) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster. Azenta provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research, and advanced cell therapies for the industry's top pharmaceutical, biotech, academic, and healthcare institutions globally.